title: Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: no.
authors.affiliation: Centre d'esclerosi múltiple de Catalunya (CEM-Cat), Neurology-Neuroimmunology department, Hospital Universitari Vall d'Hebron, Spain jrio@cem-cat.org.
authors.forename: Jordi
authors.initials: J
authors.lastname: Río
mesh_terms: D015415:Biomarkers; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care / Q000592:standards*; D066127:White Matter / Q000473:pathology*
chemical_list: D015415:Biomarkers; D007155:Immunologic Factors